Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Optimizing care for patients with non-traumatic intracerebral hemorrhage

Official title: Optimization of the Management of Non-Traumatic Intracerebral Hemorrhage (OPT-ICH)

Run by University Hospital, Tours · NCT06802588 · Data updated 2026-11-12

This study is testing a new emergency care plan for patients with non-traumatic brain bleeding to see if it can improve their treatment and recovery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment600 (estimated)
SponsorUniversity Hospital, Tours
Academic / other
Locations3 sites (Angers and 2 other locations)
StatusRecruiting
StartedMay 1, 2022
Main results expectedMay 1, 2027
Study endsMay 1, 2027
Registry record updatedJanuary 15, 2026
Trial IDNCT06802588 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who are admitted urgently to the University Hospital of Tours with a confirmed diagnosis of ICH.

Probably not a fit

Patients who have opted out of data collection will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the management of patients with non-traumatic intracerebral hemorrhage (ICH) at the University Hospital of Tours. It includes a retrospective analysis of patients admitted between 2018-2021 and a prospective evaluation of current management practices. The study focuses on implementing a standardized protocol for emergency care, including rapid imaging, antihypertensive treatment, and follow-up evaluations. The goal is to improve patient outcomes by analyzing and optimizing the acute management of ICH.

Why it matters

Potential benefit: If successful, this study could lead to improved survival rates and reduced disability for patients suffering from ICH.

How similar studies have gone: Preliminary data from other studies suggest that improved management protocols for ICH have led to better survival rates, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* aged over 18 years
* emergency admission to the University Hospital of Tours
* having an ICH on imaging performed upon admission (CT scan or MRI) at the University Hospital of Tours

Exclusion criteria :

\- Patient who has given their opposition to the collection of their data

Where it's running

  • University Hospital of Angers
    Angers, France
    Recruiting
  • University Hospital of Poitiers
    Poitiers, France
    Recruiting
  • University Hospital Center of Tours
    Tours, France
    Recruiting

Study contacts

  • Principal investigator: Marco PASI, MD, PHD — neurovascular unit, neurology department, CHRU Tours
  • Study coordinator: Marco PASI, MD, PHD
  • Email: M.PASI@chu-tours.fr
  • Phone: +33 0247478024

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.